Look for:

Products

MERCK & CO. INC.


ISIN:
US58933Y1055
WKN:
58933Y105

2022/12/02 22:03:29
Price
110.04 USD
Difference 0.22% (0.24)

General attributes

ISINUS58933Y1055
SymbolMRK
ExchangeNYSE
CurrencyUSD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)264,890 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)109.65 USD (500)
Ask (Ask size)110.13 USD (100)
Open109.00 USD
High110.09 USD
Low108.71 USD
Close (prev. day)109.80 USD
VWAP109.624469 USD
Volume (pcs)6,943,575
Trading volume761,032,593.64
Number of trades75,077
Last size1,159,913

Futures and Options

Related Futures15
Related Options-

PDF Downloads

Company report: MERCK & CO. INC.PDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research



2022/12/02 22:03:29
Price
110.04 USD
Difference 0.22% (0.24)

General attributes

ISINUS58933Y1055
SymbolMRK
ExchangeNYSE
CurrencyUSD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)264,890 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)109.65 USD (500)
Ask (Ask size)110.13 USD (100)
Open109.00 USD
High110.09 USD
Low108.71 USD
Close (prev. day)109.80 USD
VWAP109.624469 USD
Volume (pcs)6,943,575
Trading volume761,032,593.64
Number of trades75,077
Last size1,159,913

Performance and Risk

6m1Y3Y
Perf (%)+22.27%+48.92%+26.42%
Perf (abs.)+20.04+36.15+23.00
Beta0.330.270.53
Volatility21.1419.9525.77
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)109.45 USD (11,247,663)
Ø price 30 days | Ø volume 30 days (pcs.)102.38 USD (9,783,648)
Ø price 100 days | Ø volume 100 days (pcs.)93.10 USD (8,787,150)
Ø price 250 days | Ø volume 250 days (pcs.)87.17 USD (10,852,642)
YTD High | date110.98 USD (2022/12/01)
YTD Low | date72.88 USD (2022/02/24)
52 Weeks High | date110.98 USD (2022/12/01)
52 Weeks Low | date71.50 USD (2021/12/07)

Arbitrage views

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Xetra2022/12/0217:35104.40 EUR0.1425
Vienna Stock Exchange2022/12/0217:32104.40 EUR0.002
Tradegate2022/12/0222:26104.40 EUR0.5076
Stuttgart2022/12/0221:59104.40 EUR0.157
SIX Swiss Exchange2019/06/2817:3581.83 CHF0.001
SIX Swiss Exchange2020/02/0317:3675.00 USD0.001
NYSE2022/12/0222:03110.04 USD761.0375,077
Munich2022/12/0208:00104.00 EUR0.001
London Stock Exchange2022/12/0217:35109.54 USD0.008
Hanover2022/12/0208:02104.00 EUR0.001
Hamburg2022/12/0216:32104.20 EUR0.002
Frankfurt2022/12/0215:50104.20 EUR0.047
Euronext Paris2022/12/0217:24104.80 EUR0.0411
Duesseldorf2022/12/0221:00103.80 EUR0.0012
Berlin2022/12/0221:45104.40 EUR0.0018

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=2425&ID_TYPE_IMAGE_LOGO=2

Contact Details

MERCK & CO. INC.
- -
2000 Galloping Hill Road - 07033 Kenilworth
Telefon: 1-908-740-4000
Fax: -
E-mail: -

PDF Downloads

Company report: MERCK & CO. INC.PDF Download

Company Profile

Merck & Co., Inc. engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Kenilworth, NJ.

Members of Management Board

Bruce BeutelMember of Board of Directors
Christine SeidmanMember of Board of Directors
Paul RothmanMember of Board of Directors
Risa Lavizzo-MoureyMember of Board of Directors
Stephen MayoMember of Board of Directors
Douglas BakerMember of Board of Directors
Inge ThulinMember of Board of Directors
Kathy WardenMember of Board of Directors
Mary CoeMember of Board of Directors
Pamela CraigMember of Board of Directors
Patricia RussoMember of Board of Directors
Peter WendellMember of Board of Directors
Thomas GlocerMember of Board of Directors
Robert M. DavisChairman of Managing Board
Dean Y. LiMember of Executive Committee
Caroline LitchfieldMember of Executive Committee
Cristal N. DowningMember of Executive Committee
Dave WilliamsMember of Executive Committee
Frank ClyburnMember of Executive Committee
Jennifer ZacharyMember of Executive Committee
Julie L. GerberdingMember of Executive Committee
Michael A. KlobucharMember of Executive Committee
Richard R. DeLuca Jr.Member of Executive Committee
Sanat ChattopadhyayMember of Executive Committee
Steven C. MizellMember of Executive Committee






Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. Please read more information here

INFORMATION FOR CORPORATE AND INSTITUTIONAL CLIENTS

Any information, material and services regarding financial instruments and securities provided by Erste Group Bank AG or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites”) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions (the “Interested Party“).

The publication and distribution of information as well as offering and selling of products and services described on the Websites is prohibited by law in some jurisdictions. For this reason, persons in countries in which the publication as well as the offering and selling of products and services described on the Websites are not permitted by law, must not enter the Websites and/or acquire the products displayed on the Websites.

Neither Erste Group nor any third party shall offer access to the Websites or offer the products to especially, but not limited to citizen/residents of the United States and “U.S. person” (as defined in Regulation S under the US Securities Act 1933 as amended), citizen/resident of Australia, Canada, Great Britain and Japan. For this reason, the distribution or redistribution of the information, materials and products into United States, Australia, Canada, Great Britain and Japan or into any other jurisdiction where it is not permitted under the applicable law, as well as to the citizens/residents of these countries shall be prohibited.

The securities displayed on the Websites have not been and will not be registered under the US Securities Act of 1933 and trading in the securities has not been approved for purposes of the US Commodities Exchange Act of 1936. For this reason the securities may, inter alia, not be offered, sold or delivered within the United States or, for the account and benefit of U.S. persons.

The Interested Party is solely responsible to examine, whether he may enter the Websites under the law applicable to it. Erste Group shall not be responsible for the distribution of content of any of the Websites to individuals or entities which provide false information about their right to enter the Websites. For this reason Erste Group shall not be liable for any legal claims or damages which may result from the unauthorized entering or reading of the Websites.

By agreeing to this hereto, the Interested Party confirms that
(i) It has read, understood and accepted this Information and the Disclaimer;
(ii) It informed itself about any possible legal restriction and warrants that it is not restricted or prohibited to enter the Websites according to any law applicable; and
(iii) It does not make available the contents of the Websites to any person who is not qualified by law to enter the Websites.
(iV) It is no consumer.